The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus
Abstract
BACKGROUND: Short acting insulin analogue use for diabetic patients is still controversial, as reflected in many scientific debates. OBJECTIVES: To assess the effects of short acting insulin analogues versus regular human insulin. SEARCH STRATEGY: The Cochrane Library (Issue 3, 2005), MEDLINE, EMBASE until September 2005. SELECTION CRITERIA: Randomised controlled trials with an intervention duration of at least 4 weeks. DATA COLLECTION AND ANALYSIS: Trial selection and evaluation of study quality was done independently by two reviewers. MAIN RESULTS: Altogether 8274 participants took part in 49 randomised controlled studies. Most studies were of poor methodological quality. In patients with type 1 diabetes, the weighted mean difference (WMD) of HbA1c was -0.1% (95% CI: -0.2 to -0.1) in favour of insulin analogue, whereas in patients with type 2 diabetes the WMD was 0.0% (95% CI: -0.1 to 0.0). In subgroup analyses of different types of interventions in type 1 diabetic patients, the WMD in HbA1c was -0.2% (95% CI: -0.3 to -0.1) in favour of insulin analogue in studies using continuous subcutaneous insulin injections (CSII), whereas for conventional intensified insulin therapy (IIT) studies the WMD in HbA1c was -0.1% (95% CI: -0.1 to 0.0). The WMD of the overall mean hypoglycaemic episodes per patient per month was -0.2 (95% CI: -1.1 to 0.7) and -0.2 (95% CI: -0.5 to 0.1) for analogues in comparison to regular insulin in patients with type 1 diabetes and type 2 diabetes, respectively. For studies in type 1 diabetes patients the incidence of severe hypoglycaemia ranged from 0 to 247.3 (median 21.8) episodes per 100 person-years for insulin analogues and from 0 to 544 (median 46.1) for regular insulin, in type 2 the incidence ranged from 0 to 30.3 (median 0.3) episodes per 100 person-years for insulin analogues and from 0 to 50.4 (median 1.4) for regular insulin. No study was designed to investigate possible long term effects (e.g. mortality, diabetic complications), in particular in patients with diabetes related complications. AUTHORS' CONCLUSIONS: Our analysis suggests only a minor benefit of short acting insulin analogues in the majority of diabetic patients treated with insulin. Until long term efficacy and safety data are available we suggest a cautious response to the vigorous promotion of insulin analogues. For safety purposes, we need a long-term follow-up of large numbers of patients and well designed studies in pregnant women to determine the safety profile for both the mother and the unborn child.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Coefficient of Agreement for Nominal Scales
Cohen, J. (1960) · Educational and Psychological Measurement · doi:10.1177/001316446002000104 · Cited by 42,398
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes.
Cryer, P. (2002) · Diabetologia · doi:10.1007/s00125-002-0822-9 · Cited by 794
Kunz, R., & Oxman, A. D. (1998) · BMJ · doi:10.1136/bmj.317.7167.1185 · Cited by 770
Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739
Handbook of Psychology and Diabetes
(2013) · Routledge eBooks · doi:10.4324/9781315077369 · Cited by 661
Fear of hypoglycemia: quantification, validation, and utilization
Cox, D. J., Irvine, A., Gonder-Frederick, L., Nowacek, G., & Butterfield, J. (1987) · Diabetes Care · doi:10.2337/diacare.10.5.617 · Cited by 579
The DCCT Research Group (1988) · Diabetes Care · doi:10.2337/diacare.11.9.725 · Cited by 509
[Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human Insulin
Howey, D. C., Bowsher, R. R., Brunelle, R. L., & Woodworth, J. R. (1994) · Diabetes · doi:10.2337/diab.43.3.396 · Cited by 472
Randomized Controlled Trials: Questions, Answers, and Musings
Jadad, A. R., & Enkin, M. W. (2007) · Wiley eBooks · doi:10.1002/9780470691922 · Cited by 458
King, G. L., Goodman, A. D., Buzney, S., Moses, A., & Kahn, C. R. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111764 · Cited by 437
Bradley, C., & Lewis, K. S. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01421.x · Cited by 379
Lotter, V. (1978) · Autism · doi:10.1007/978-1-4684-0787-7_32 · Cited by 367
Insulin analogues and their potential in the management of diabetes mellitus
Bolli, G. B., Di Marchi, R. D., Park, G. D., Pramming, S., & Koivisto, V. A. (1999) · Diabetologia · doi:10.1007/s001250051286 · Cited by 349
Anderson, J. H., Brunelle, R. L., Koivisto, V. A., Pfützner, A., Trautmann, M. E., Vignati, L., & DiMarchi, R. (1997) · Diabetes · doi:10.2337/diab.46.2.265 · Cited by 319
Insulin Lispro in CSII: Results of a Double-Blind Crossover Study
Zinman, B., Tildesley, H., Chiasson, J.-L., Tsui, E., & Strack, T. (1997) · Diabetes · doi:10.2337/diab.46.3.440 · Cited by 258
Metabolic and immunologic effects of insulin lispro in gestational diabetes.
Jovanovic, L., Ilic, S., Pettitt, D. J., Hugo, K., Gutierrez, M., Bowsher, R. R., & Bastyr, E. J. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1422 · Cited by 238
Home, P. D., Lindholm, A., Hylleberg, B., & Round, P. (1998) · Diabetes Care · doi:10.2337/diacare.21.11.1904 · Cited by 234
Home, P. D., Lindholm, A., Riis, A., & for the European Insulin Aspart Study Group (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00380.x · Cited by 232
Raskin, P., Guthrie, R. A., Leiter, L., Riis, A., & Jovanovic, L. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.583 · Cited by 230
Brunelle, R. L., Llewelyn, J., Anderson, J. H., Gale, E. A. M., & Koivisto, V. A. (1998) · Diabetes Care · doi:10.2337/diacare.21.10.1726 · Cited by 216
Meta‐analysis combining parallel and cross‐over clinical trials. I: Continuous outcomes
Curtin, F., Altman, D. G., & Elbourne, D. (2002) · Statistics in Medicine · doi:10.1002/sim.1205 · Cited by 207
Validation of a Diabetes-Specific Quality-of-Life Scale for Patients With Type 1 Diabetes
Bott, U., Mühlhauser, I., Overmann, H., & Berger, M. (1998) · Diabetes Care · doi:10.2337/diacare.21.5.757 · Cited by 204
Lalli, C., Ciofetta, M., Del Sindaco, P., Torlone, E., Pampanelli, S., Compagnucci, P., Cartechini, M. G., Bartocci, L., Brunetti, P., & Bolli, G. B. (1999) · Diabetes Care · doi:10.2337/diacare.22.3.468 · Cited by 195
The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease
Haffner, S. M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0343 · Cited by 193
Anderson, J. H. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.11.1249 · Cited by 193
Grant, M. B., Mames, R. N., Fitzgerald, C., Ellis, E. A., Aboufriekha, M., & Guy, J. (1993) · Diabetologia · doi:10.1007/bf00400229 · Cited by 191
Boehm, B. O., Home, P. D., Behrend, C., Kamp, N. M., & Lindholm, A. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00733.x · Cited by 176
Renner, R., Pfützner, A., Trautmann, M., Harzer, O., Sauter, K., & Landgraf, R. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.784 · Cited by 168
Alberti, K. G. M. M., & Krall, L. P. (1985) · Elsevier eBooks · Cited by 158
A Direct Comparison of Insulin Aspart and Insulin Lispro in Patients With Type 1 Diabetes
Plank, J., Wutte, A., Brunner, G., Siebenhofer, A., Semlitsch, B., Sommer, R., Hirschberger, S., & Pieber, T. R. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2053 · Cited by 158
Self-citationBode, B., Weinstein, R., Bell, D., McGill, J., Nadeau, D., Raskin, P., Davidson, J., Henry, R., Huang, W.-C., & Reinhardt, R. R. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.439 · Cited by 148
Heller, S. R., Amiel, S. A., & Mansell, P. (1999) · Diabetes Care · doi:10.2337/diacare.22.10.1607 · Cited by 147
Melki, V., Renard, É., Lassmann-Vague, V., Boivin, S., Guerci, B., Hanaire, H. P., Bringer, J., Bélicar, P., Jeandidier, N., Meyer, L., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.6.977 · Cited by 137
Holleman, F., Schmitt, H., Rottiers, R., Rees, A., Symanowski, S., Anderson, J. H., & The Benelux-UK Insulin Lispro Study Group (1997) · Diabetes Care · doi:10.2337/diacare.20.12.1827 · Cited by 136
Torlone, E., Fanelli, C. G., Rambotti, A. M., Kassi, G., Modarelli, F., Vincenzo, A. D., Epifano, L., Ciofetta, M., Pampanelli, S., Brunetti, P., et al. (1994) · Diabetologia · doi:10.1007/bf00417697 · Cited by 136
The Physiologic Replacement of Insulin
Oates, J. A., Wood, A. J. J., & Zinman, B. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210605 · Cited by 131
Modeling absorption kinetics of subcutaneous injected soluble insulin
Mosekilde, E., Jensen, K. S., Binder, C., Pramming, S., & Thorsteinsson, B. (1989) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059088 · Cited by 129
Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects.
Homko, C., Deluzio, A., Jimenez, C. C., Kolaczynski, J., & Boden, G. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2027 · Cited by 118
Mühlhauser, I., Overmann, H., Bender, R., Bott, U., & Berger, M. (1998) · Diabetologia · doi:10.1007/s001250051065 · Cited by 117
Kotsanos, J. G., Vignati, L., Huster, W. J., Andrejasich, C. M., Boggs, M. B., Jacobson, A. M., Marrero, D. G., Mathias, S. D., Patrick, D. L., Zalani, S., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.6.948 · Cited by 116
Improved mealtime treatment of diabetes mellitus using an insulin analogue
Anderson, J., Brunelle, R. L., Koivisto, V. A., Trautmann, M. E., Vignati, L., & DiMarchi, R. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80073-2 · Cited by 116
Kilo, C., Mezitis, N. H. E., Jain, R., Mersey, J. H., McGill, J. B., & Raskin, P. (2003) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(03)00076-x · Cited by 113
Gale, E. A. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00258.x · Cited by 112
Bode, B. W., & Strange, P. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.69 · Cited by 112
Garg, S. K., Rosenstock, J., & Ways, K. (2005) · Endocrine Practice · doi:10.4158/ep.11.1.11 · Cited by 110
Roach, P. J., Yue, L., & Arora, V. K. (1999) · Diabetes Care · doi:10.2337/diacare.22.8.1258 · Cited by 108
Mecacci, F., Carignani, L., Cioni, R., Bartoli, E., Parretti, E., Torre, P. L., Scarselli, G., & Mello, G. (2003) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(03)00157-x · Cited by 105
Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus
Persson, B., Swahn, M.-L., Hjertberg, R., Hanson, U., Nord, E., Nordlander, E., & Hansson, L.-O. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00141-9 · Cited by 103
Ciofetta, M., Lalli, C., Sindaco, P., Torlone, E., Pampanelli, S., Mauro, L., Chiara, D. L., Brunetti, P., & Bolli, G. B. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.795 · Cited by 99
Brunner, G. A., Hirschberger, S., Sendlhofer, G., Wutte, A., Ellmerer, M., Balent, B., Schaupp, L., Krejs, G. J., & Pieber, T. R. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00289.x · Cited by 99
Self-citationHeller, S. R., Colagiuri, S., Vaaler, S., Wolffenbuttel, B. H. R., Koelendorf, K., Friberg, H. H., Windfeld, K., & Olinder, A. L. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01244.x · Cited by 96
Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes
Boehm, B. O., Vaz, J. A., Brøndsted, L., & Home, P. (2004) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2004.10.001 · Cited by 96
Sindaco, P., Ciofetta, M., Lalli, C., Perriello, G., Pampanelli, S., Torlone, E., Brunetti, P., & Bolli, G. B. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199807)15:7<592::aid-dia625>3.0.co;2-j · Cited by 96
Colquitt, J. L., Royle, P., & Waugh, N. R. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01018.x · Cited by 95
Pfützner, A. H., Küstner, E., Forst, T. M., Schleppinghoff, B. S., TRAUTMANN, M. E., Haslbeck, M., Schatz, H., & Beyer, J. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211418 · Cited by 92
Treatment of type 1 diabetes with insulin lispro during Ramadan.
Kadiri, A., Al-Nakhi, A., El-Ghazali, S., Jabbar, A. H., Arouj, M. A., Akram, J., Wyatt, J., Assem, A., & Ristic, S. (2001) · PubMed · Cited by 90
Garg, S. K., Carmain, J. A., Braddy, K. C., Anderson, J., Vignati, L., Jennings, M. K., & Chase, H. P. (1996) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199601)13:1<47::aid-dia999>3.0.co;2-m · Cited by 86
Herman, W. H. (2002) · Clinical Diabetes · doi:10.2337/diaclin.20.1.22 · Cited by 86
Bott, U., Ebrahim, S. H., Hirschberger, S., & Skovlund, S. E. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01010.x · Cited by 85
Fineberg, N. S., Fineberg, S. E., Anderson, J. H., Birkett, M. A., Gibson, R. G., & Hufferd, S. (1996) · Diabetes · doi:10.2337/diab.45.12.1750 · Cited by 85
McSorley, P., Bell, P. M., Jacobsen, L. V., Kristensen, A., & Lindholm, A. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85129-3 · Cited by 82
Insulin Lispro Lowers Postprandial Glucose in Prepubertal Children With Diabetes
Deeb, L. C., Holcombe, J. H., Brunelle, R. L., Zalani, S., Brink, S. J., Jenner, M., Kitson, H. F., Perlman, K., & Spencer, M. L. (2001) · PEDIATRICS · doi:10.1542/peds.108.5.1175 · Cited by 81
Roach, P. J., TRAUTMANN, M. E., Arora, V. K., Sun, B., & Anderson, J. H. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88307-1 · Cited by 80
Tamás, G., Marre, M., Astorga, R., Dedov, I. I., Jacobsen, J. B., & Olinder, A. L. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00262-5 · Cited by 78
Jacobs, M., Keulen, E. T. P., Kanc, K., Casteleijn, S., Scheffer, P. G., Devillé, W. L. J. M., & Heine, R. J. (1997) · Diabetes Care · doi:10.2337/diacare.20.8.1279 · Cited by 77
Gerstein, H. C., & Haynes, R. B. (2001) · Cited by 75
Postprandial Insulin Lispro: A new therapeutic option for type 1 diabetic patients
Schernthaner, G., Wein, W., Sandholzer, K., Equiluz-Bruck, S., BATES, P. C., & Birkett, M. A. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.570 · Cited by 74
Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes.
KAUFMAN, F. R., Halvorson, M., Kim, C. S., & Pitukcheewanont, P. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.579 · Cited by 71
Raskin, P., Holcombe, J. H., Tamborlane, W. V., Malone, J. I., Strowig, S., Ahern, J. A., & Lavent, F. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00168-4 · Cited by 71
Bretzel, R. G., Arnolds, S., Medding, J., & Linn, T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1023 · Cited by 68
Holcombe, J. H., Zalani, S., Arora, V. K., & Mast, C. J. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85138-4 · Cited by 68
Ross, S., Zinman, B., Campos, R. V., & Strack, T. R. (2001) · PubMed · Cited by 67
Time-action Profile of the Insulin Analogue B28Asp
Heinemann, L., Kapitza, C., Starke, A. A. R., & Heise, T. (1996) · Diabetic Medicine · Cited by 64
Ahmed, A. B., & Home, P. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.32 · Cited by 61
DeVries, J. H., Olinder, A. L., Jacobsen, J. L., Heine, R. J., Home, P. D., & The Tri‐Continental Insulin Aspart Study Group (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00936.x · Cited by 56
Ford‐Adams, M., Murphy, N., Moore, E., Edge, J., Ong, K. K., Watts, A., Acerini, C. L., & Dunger, D. B. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01013.x · Cited by 56
Vignati, L., Anderson, J. H., & Iversen, P. W. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80014-8 · Cited by 54
Tupola, S. J., Komulainen, J., Jääskeläinen, J., & Sipilä, I. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00564.x · Cited by 52
Pramming, S., Thorsteinsson, B., Bendtson, I., & Binder, C. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00292.x · Cited by 52
(2004) · PubMed · Cited by 51
Ferguson, S. C., Strachan, M. W. J., Janes, J., & Frier, B. M. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.202 · Cited by 47
Colombel, A., Murat, A., Krempf, M., Kuchly‐Anton, B., & Charbonnel, B. H. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00077.x · Cited by 46
Nielsen, F. S., J�rgensen, L. N., Ipsen, M., Voldsgaard, A. I., & Parving, H. ‐. (1995) · Diabetologia · doi:10.1007/bf00400729 · Cited by 45
Effects of Mixing Glargine and Short-Acting Insulin Analogs on Glucose Control
Kaplan, W., Rodríguez, L. M., Smith, O., Haymond, M. W., & Heptulla, R. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2739 · Cited by 41
Tubiana‐Rufi, N., Coutant, R., Bloch, J., Munz-Licha, G., Delcroix, C., Montaud-Raguideau, N., Ducrocq, R., Limal, J. M., & Czernichow, P. (2004) · Hormone Research in Paediatrics · doi:10.1159/000081703 · Cited by 38
Clinical outcomes with insulin lispro compared with human regular insulin: a meta-analysis
Davey, P., Grainger, D., MacMillan, J., Rajan, N., Aristides, M., & Gliksman, M. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80091-4 · Cited by 36
Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin?
Schmauβ, S., König, A., & Landgraf, R. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199803)15:3<247::aid-dia547>3.0.co;2-t · Cited by 33
Johansson, U., Adamson, U. C., Lins, P. E., & Wredling, R. (2000) · PubMed · Cited by 33
Gallagher, A., & Home, P. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.07.010 · Cited by 29
Annuzzi, G., Prato, S. D., Arcari, R., Damato, A. B., Benzi, L., Bruttomesso, D., Calderini, M. C., Coscelli, C., Fedele, D., Galluzzo, A., et al. (2001) · PubMed · Cited by 27
Bastyr, E. J., Huang, Y., Brunelle, R. L., Vignati, L., Cox, D. J., & Kotsanos, J. G. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00066.x · Cited by 27
Roach, P. J., Strack, T. R., Arora, V. K., & Zhao, Z. (2001) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2001.tb11010.x · Cited by 26
Recasens, M., Aguilera, E., Morínigo, R., Casamitjana, R., Nicoletti, F., Gomis, R., & Conget, I. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00036-6 · Cited by 24
Janssen, M. M., Snoek, F. J., Masurel, N., Hoogma, R. P. L. M., Devillé, W. L. J. M., Popp‐Snijders, C., & Heine, R. J. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.629 · Cited by 24
Impact of insulin lispro on HbA 1c values in insulin pump users
Garg, S. K., Anderson, J. H., Gerard, L., MacKenzie, T. A., Gottlieb, P. A., Jennings, M. K., & Chase, H. P. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00108.x · Cited by 22
Altuntaş, Y., Ozen, B., Ozturk, B., Şengül, A. M., Uçak, S., Ersoy, Ö., & Karul, S. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00283.x · Cited by 21
Herz, M., Arora, V. K., Campaigne, B. N., Scholtz, H. E., Potgieter, M., & Mollentze, W. F. (2003) · PubMed · Cited by 21
Herz, M., Profozić, V., Arora, V. K., Duvnjak, L. S., Kovačević, I., Boras, J., Campaigne, B. N., & Metelko, Ž. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000615 · Cited by 18
Herz, M., Arora, V. K., Sun, B., Ferguson, S. C., Bolli, G. B., & Frier, B. M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00830.x · Cited by 18
Provenzano, C., Vero, R., Oliva, A. B. G., et al. (2001) · PubMed · Cited by 18
Martin, D., Licha‐Müntz, G., Grasset, E., Grenèche, M. O., Nouet, D., François, L., Legrand, C., Polak, M., Augendre‐Ferrante, B., Tubiana‐Rufi, N., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00845.x · Cited by 16
Hedman, C. A., Orre‐Pettersson, A. ‐., Lindström, T., & Arnqvist, H. J. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01327.x · Cited by 15
Sargın, H., Sargın, M., Altuntaş, Y., Şengül, A. M., Orbay, E., Seber, S., Uçak, S., & Yayla, A. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00167-0 · Cited by 15
Tsui, E. Y. L., Chiasson, J., Tildesley, H. D., Barnie, A., Simkins, S., Strack, T. R., & Zinman, B. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.93 · Cited by 12
Heller, S. R., Amiel, S. A., Evans, M. L., Kong, M., Macdonald, I. A., & Peacey, S. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00186.x · Cited by 12
Iwamoto, Y., Akanuma, Y., Niimi, H., et al. (2001) · 糖尿病 · Cited by 10
Chan, W. B., Chow, C. C., Yeung, V. T. F., et al. (2004) · PubMed · Cited by 9
Insulin lispro improves postprandial glucose control in patients with diabetes mellitus.
Škrha, J., Šmahelová, A., Anděl, M., Vrtovec, M., Subić, J., Kreze, A., Vozár, J., Korecova, M., Verga, V. D., Wyatt, J., et al. (2002) · PubMed · Cited by 8
Insulin Lispro: A critical evaluation
Shukla, V. K., Pharm, B. S., & Otten, N. (1999) · Cited by 2
Cited by
Daneman, D. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68341-4 · Cited by 921
Three-year efficacy of complex insulin regimens in type 2 diabetes
Holman, R. R., Farmer, A. J., Davies, M. J., Levy, J. C., Darbyshire, J. L., Keenan, J. F., & Paul, S. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905479 · Cited by 667
Update on the treatment of type 2 diabetes mellitus
Marín-Peñalver, J. J., Martín-Timón, I., Sevillano-Collantes, C., & Cañizo-Gómez, F. J. D. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i17.354 · Cited by 647
“Also, when necessary, the insulin analogs are preferable to short regular human insulin, due to its lower rate of hypoglycaemia [270] .”
BackgroundHypoglycaemia in diabetes mellitus: epidemiology and clinical implications
Frier, B. M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.170 · Cited by 481
Jeitler, K., Horvath, K., Berghold, A., Gratzer, T. W., Neeser, K., Pieber, T. R., & Siebenhofer, A. (2008) · Diabetologia · doi:10.1007/s00125-008-0974-3 · Cited by 375
Self-citation
Metadata
- Authors
- Siebenhofer, A., Plank, J., Berghold, A., Jeitler, K., Horvath, K., Narath, M., Gfrerer, R., & Pieber, T. R.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2006-04-19
- Issue
- 2
- Pages
- CD003287-CD003287
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1915612727
- Cited by
- 264
- References
- 117
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.